Literature DB >> 24327959

Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis.

Melanie Kahle1, Marion Horsch, Barbara Fridrich, Anett Seelig, Jürgen Schultheiß, Jörn Leonhardt, Martin Irmler, Johannes Beckers, Birgit Rathkolb, Eckhard Wolf, Nicole Franke, Valérie Gailus-Durner, Helmut Fuchs, Martin Hrabě de Angelis, Susanne Neschen.   

Abstract

Genetic predisposition and environmental factors contribute to an individual's susceptibility to develop hepatosteatosis. In a systematic, comparative survey we focused on genotype-dependent and -independent adaptations early in the pathogenesis of hepatosteatosis by characterizing C3HeB/FeJ, C57BL/6NTac, C57BL/6J, and 129P2/OlaHsd mice after 7, 14, or 21 days high-fat-diet exposure. Strain-specific metabolic responses during diet challenge and liver transcript signatures in mild hepatosteatosis outline the suitability of particular strains for investigating the relationship between hepatocellular lipid content and inflammation, glucose homeostasis, insulin action, or organelle physiology. Genetic background-independent transcriptional adaptations in liver paralleling hepatosteatosis suggest an early increase in the organ's vulnerability to oxidative stress damage what could advance hepatosteatosis to steatohepatitis. "Universal" adaptations in transcript signatures and transcription factor regulation in liver link insulin resistance, type 2 diabetes mellitus, cancer, and thyroid hormone metabolism with hepatosteatosis, hence, facilitating the search for novel molecular mechanisms potentially implicated in the pathogenesis of human non-alcoholic-fatty-liver-disease.

Entities:  

Keywords:  129, 129P2/OlaHsd; ALT, alanine aminotransferase; B6J, C57BL/6J; B6N, C57BL/6NTac; C3H, C3HeB/FeJ; Cancer; HDL, high-density lipoprotein; HFD, high-fat diet; IR, insulin resistance; Inflammation; Insulin resistance; LDL, low-density lipoprotein; LFD, low fat rodent laboratory diet; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic hepatosteatitis; Non-alcoholic fatty liver disease; Oxidative stress; T2D, type 2 diabetes mellitus; TAG, triacylglycerol; Thyroid metabolism; VLDL, very low density lipoprotein; WAT, white adipose tissue

Year:  2013        PMID: 24327959      PMCID: PMC3855089          DOI: 10.1016/j.molmet.2013.07.009

Source DB:  PubMed          Journal:  Mol Metab        ISSN: 2212-8778            Impact factor:   7.422


  59 in total

Review 1.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

Review 2.  Thyroid hormone and gene expression in the regulation of mitochondrial respiratory function.

Authors:  T M Pillar; H J Seitz
Journal:  Eur J Endocrinol       Date:  1997-03       Impact factor: 6.664

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  GATA Transcription Factors and Cancer.

Authors:  Rena Zheng; Gerd A Blobel
Journal:  Genes Cancer       Date:  2010-12

5.  Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene.

Authors:  Anthony Nicholson; Peter C Reifsnyder; Rachel D Malcolm; Charlotte A Lucas; Grant R MacGregor; Weidong Zhang; Edward H Leiter
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 7.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

8.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  Why can insulin resistance be a natural consequence of thyroid dysfunction?

Authors:  Gabriela Brenta
Journal:  J Thyroid Res       Date:  2011-09-19

10.  Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism.

Authors:  Justin H Berger; Maureen J Charron; David L Silver
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more
  35 in total

1.  Regulation of fatty acid trafficking in liver by thioesterase superfamily member 1.

Authors:  Anal Desai; Michele Alves-Bezerra; Yingxia Li; Cafer Ozdemir; Curtis J Bare; Yue Li; Susan J Hagen; David E Cohen
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

2.  Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice.

Authors:  K Stemmer; P Kotzbeck; F Zani; M Bauer; C Neff; T D Müller; P T Pfluger; R J Seeley; S Divanovic
Journal:  Int J Obes (Lond)       Date:  2014-10-28       Impact factor: 5.095

3.  Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment.

Authors:  Noura S Dosoky; Zhongyi Chen; Yan Guo; Clara McMillan; C Robb Flynn; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2019-06-15       Impact factor: 4.813

4.  Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.

Authors:  Marin E Healy; Jenny D Y Chow; Frances L Byrne; David S Breen; Norbert Leitinger; Chien Li; Carolin Lackner; Stephen H Caldwell; Kyle L Hoehn
Journal:  J Hepatol       Date:  2014-10-23       Impact factor: 25.083

Review 5.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

6.  Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistance.

Authors:  Darren C Henstridge; E Estevez; T L Allen; S E Heywood; T Gardner; C Yang; N A Mellett; B A Kingwell; P J Meikle; M A Febbraio
Journal:  Cell Stress Chaperones       Date:  2015-01-25       Impact factor: 3.667

7.  Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain.

Authors:  Rizaldy C Zapata; Olivia Osborn
Journal:  Physiol Behav       Date:  2020-03-07

Review 8.  Animal models of obesity and diabetes mellitus.

Authors:  Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2018-01-19       Impact factor: 43.330

9.  The Epoxyeicosatrienoic Acid Pathway Enhances Hepatic Insulin Signaling and is Repressed in Insulin-Resistant Mouse Liver.

Authors:  Alexander Schäfer; Susanne Neschen; Melanie Kahle; Hakan Sarioglu; Tobias Gaisbauer; Axel Imhof; Jerzy Adamski; Stefanie M Hauck; Marius Ueffing
Journal:  Mol Cell Proteomics       Date:  2015-06-12       Impact factor: 5.911

10.  The genetic architecture of NAFLD among inbred strains of mice.

Authors:  Simon T Hui; Brian W Parks; Elin Org; Frode Norheim; Nam Che; Calvin Pan; Lawrence W Castellani; Sarada Charugundla; Darwin L Dirks; Nikolaos Psychogios; Isaac Neuhaus; Robert E Gerszten; Todd Kirchgessner; Peter S Gargalovic; Aldons J Lusis
Journal:  Elife       Date:  2015-06-12       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.